Sildenafil + Placebo + Vardenafil (Levitra, BAY38-9456) + Placebo
ApprovedCompleted 0 views this week 0 watching⚡ Active
Interest: 40/100
40
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedAbout Sildenafil + Placebo + Vardenafil (Levitra, BAY38-9456) + Placebo
Sildenafil + Placebo + Vardenafil (Levitra, BAY38-9456) + Placebo is a approved stage product being developed by Bayer for Safety. The current trial status is completed. This product is registered under clinical trial identifier NCT00461565. Target conditions include Safety.
What happened to similar drugs?
2 of 3 similar drugs in Safety were approved
Approved (2) Terminated (0) Active (1)
Hype Score Breakdown
Clinical
20
Activity
8
Company
12
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00461565 | Approved | Completed |
Competing Products
20 competing products in Safety